CS4-12535-93739
3 vaccinations
4 coded responses
10 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 945 / CA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-27
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-17
Survey response — day 7, dose 2MedDRA: Asthenia, Chills, Dizziness, Headache, Lethargy, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · NauseaFree text: These questions are for several days after the second shot. I did not get a health check in for December 21. On that day however I did have fevers chills lethargy headache dizziness nausea weakness and myalgias. Symptoms were severe lasted 1 1/2 days. I was tested in case it was Covid my test was negative. Since then I have had no recurrent symptoms so when I have been submitting my answers it has missed my reaction.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Hallucination, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: Hallucination, axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesFree text: Axillary and supraclavicular lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body achesFree text: Axillary and supraclavicular lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): These questions are for several days after the second shot. I did not get a health check in for December 21. On that day however I did have fevers chills lethargy headache dizziness nausea weakness and myalgias. Symptoms were severe lasted 1 1/2 days. I was tested in case it was Covid my test was negative. Since then I have had no recurrent symptoms so when I have been submitting my answers it has missed my reaction.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Hallucination, axillary lymphadenopathy
Systemic reaction (other): Axillary and supraclavicular lymphadenopathy
Systemic reaction (other): Axillary and supraclavicular lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hallucination | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Lethargy | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release